
Voyager Therapeutics, Inc.
VYGRHealthcare|Biotechnology|US
$1.86
+0.14 (+8.43%)
Tangible Book / Share
$2.19
Cash / Share
$1.73
Ownership Breakdown
83.7%
Float
61.6M
Shares Outstanding
51.6M
Float Shares
Major Holders (7)
Combined: 47.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Israel A. Englander | Individual | 7.40% | 4,442,951 | Jul 31, 2026 | 13D/G |
| Millennium Group Management LLC | Other | 7.40% | 4,442,951 | Jul 31, 2026 | 13D/G |
| Millennium Management LLC | Other | 7.40% | 4,442,951 | Jul 31, 2026 | 13D/G |
| Integrated Core Strategies (US) LLC | Other | 7.30% | 4,437,293 | Jul 31, 2026 | 13D/G |
| BlackRock, Inc. | Holding company | 6.40% | 3,525,532 | Apr 24, 2025 | 13D/G |
| Armistice Capital, LLC | IA, OO | 5.58% | 3,436,000 | Aug 14, 2026 | 13D/G |
| Steven Boyd | HC, IN | 5.58% | 3,436,000 | Aug 14, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 2,362,250 acquired · 87,875 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Carter Todd Alfred | Chief Scientific Officer | Nov 1, 2026 | AWARD | 33,000 | — | — | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Nov 1, 2026 | AWARD | 154,000 | $1.72 | $264.9K | Form 4 |
| Swartz Robin | President | Nov 1, 2026 | AWARD | 318,500 | $1.72 | $547.8K | Form 4 |
| Swartz Robin | President | Nov 1, 2026 | AWARD | 68,250 | — | — | Form 4 |
| SCANGOS GEORGE A | director | Jun 9, 2026 | AWARD | 30,000 | $3.43 | $102.9K | Form 4 |
| MACKEY CATHERINE J | director | Jun 9, 2026 | AWARD | 30,000 | $3.43 | $102.9K | Form 4 |
| Hyman Steven | director | Jun 9, 2026 | AWARD | 30,000 | $3.43 | $102.9K | Form 4 |
| Vitale Nancy | director | Jun 9, 2026 | AWARD | 30,000 | $3.43 | $102.9K | Form 4 |
| Higgins Michael J | director | Jun 9, 2026 | AWARD | 30,000 | $3.43 | $102.9K | Form 4 |
| Onyia Jude | director | Jun 9, 2026 | AWARD | 30,000 | $3.43 | $102.9K | Form 4 |
| GERAGHTY JAMES A | director | Jun 9, 2026 | AWARD | 30,000 | $3.43 | $102.9K | Form 4 |
| Colon Grace | director | Jun 9, 2026 | AWARD | 30,000 | $3.43 | $102.9K | Form 4 |
| PIERCE GLENN | director | Jun 9, 2026 | AWARD | 30,000 | $3.43 | $102.9K | Form 4 |
| Quinlan Amy | Principal Accounting Officer | May 8, 2026 | OTHER | 0 | — | — | Form 4 |
| Quinlan Amy | Principal Accounting Officer | May 8, 2026 | OTHER | 50,000 | $5.28 | $264.0K | Form 4 |
| Quinlan Amy | Principal Accounting Officer | May 8, 2026 | OTHER | 28,500 | $3.68 | $104.9K | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Apr 2, 2026 | SELL | 11,511 | $3.87 | $44.5K | Form 4 |
| Shiferman Gregory L. | SVP and General Counsel | Apr 1, 2026 | AWARD | 50,000 | — | — | Form 4 |
| Swartz Robin | COO & CBO | Feb 24, 2026 | SELL | 6,458 | $3.77 | $24.3K | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Feb 24, 2026 | SELL | 14,197 | $3.79 | $53.8K | Form 4 |
| Jorgensen Nathan D. | Chief Financial Officer | Feb 24, 2026 | SELL | 4,668 | $3.77 | $17.6K | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 24, 2026 | SELL | 4,174 | $3.76 | $15.7K | Form 4 |
| Swartz Robin | COO & CBO | Feb 18, 2026 | SELL | 3,882 | $3.44 | $13.4K | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 18, 2026 | SELL | 3,301 | $3.44 | $11.4K | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Feb 18, 2026 | SELL | 11,732 | $3.41 | $40.0K | Form 4 |
| Swartz Robin | COO & CBO | Feb 10, 2026 | SELL | 4,569 | $3.85 | $17.6K | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Feb 10, 2026 | SELL | 12,192 | $3.78 | $46.1K | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 10, 2026 | SELL | 3,525 | $3.85 | $13.6K | Form 4 |
| Ferguson Toby | Chief Medical Officer | Feb 6, 2026 | AWARD | 210,000 | $3.68 | $772.8K | Form 4 |
| Ferguson Toby | Chief Medical Officer | Feb 6, 2026 | AWARD | 45,000 | — | — | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 6, 2026 | AWARD | 33,000 | — | — | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 6, 2026 | AWARD | 154,000 | $3.68 | $566.7K | Form 4 |
| Swartz Robin | COO & CBO | Feb 6, 2026 | AWARD | 45,000 | — | — | Form 4 |
| Swartz Robin | COO & CBO | Feb 6, 2026 | AWARD | 210,000 | $3.68 | $772.8K | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Feb 6, 2026 | AWARD | 86,250 | — | — | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Feb 6, 2026 | AWARD | 402,500 | $3.68 | $1.5M | Form 4 |
| Jorgensen Nathan D. | Chief Financial Officer | Feb 6, 2026 | AWARD | 32,250 | — | — | Form 4 |
| Jorgensen Nathan D. | Chief Financial Officer | Feb 6, 2026 | AWARD | 150,500 | $3.68 | $553.8K | Form 4 |
| Shiferman Gregory L. | SVP and General Counsel | Jan 6, 2026 | AWARD | 100,000 | $4.02 | $402.0K | Form 4 |
| Shiferman Gregory L. | officer | Jan 6, 2026 | OTHER | 0 | — | — | Form 4 |
| Jorgensen Nathan D. | Chief Financial Officer | Oct 3, 2025 | SELL | 7,666 | $4.78 | $36.6K | Form 4 |
| Ferguson Toby | Chief Medical Officer | Aug 18, 2025 | SELL | 19,000 | $3.73 | $70.9K | Form 4 |
| Vitale Nancy | director | Jun 3, 2025 | AWARD | 24,000 | $3.28 | $78.7K | Form 4 |
| SCANGOS GEORGE A | director | Jun 3, 2025 | AWARD | 24,000 | $3.28 | $78.7K | Form 4 |
| PIERCE GLENN | director | Jun 3, 2025 | AWARD | 24,000 | $3.28 | $78.7K | Form 4 |
| Onyia Jude | director | Jun 3, 2025 | AWARD | 24,000 | $3.28 | $78.7K | Form 4 |
| MACKEY CATHERINE J | director | Jun 3, 2025 | AWARD | 24,000 | $3.28 | $78.7K | Form 4 |
| Hyman Steven | director | Jun 3, 2025 | AWARD | 24,000 | $3.28 | $78.7K | Form 4 |
| Higgins Michael J | director | Jun 3, 2025 | AWARD | 24,000 | $3.28 | $78.7K | Form 4 |
| GERAGHTY JAMES A | director | Jun 3, 2025 | AWARD | 24,000 | $3.28 | $78.7K | Form 4 |
| Colon Grace | director | Jun 3, 2025 | AWARD | 24,000 | $3.28 | $78.7K | Form 4 |
| Ferguson Toby | Chief Medical Officer | Apr 2, 2025 | SELL | 10,086 | $3.43 | $34.6K | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Apr 2, 2025 | SELL | 10,885 | $3.43 | $37.3K | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 21, 2025 | AWARD | 46,000 | — | — | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 21, 2025 | AWARD | 92,000 | $4.22 | $388.2K | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 20, 2025 | SELL | 3,305 | $4.26 | $14.1K | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Feb 21, 2025 | AWARD | 145,000 | — | — | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Feb 20, 2025 | SELL | 11,702 | $4.24 | $49.6K | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Feb 21, 2025 | AWARD | 290,000 | $4.22 | $1.2M | Form 4 |
| Swartz Robin | COO & CBO | Feb 21, 2025 | AWARD | 71,250 | — | — | Form 4 |
| Swartz Robin | COO & CBO | Feb 21, 2025 | AWARD | 142,500 | $4.22 | $601.4K | Form 4 |
| Swartz Robin | COO & CBO | Feb 20, 2025 | SELL | 3,894 | $4.25 | $16.5K | Form 4 |
| Fahey Sandell Jacquelyn | Chief Legal Officer | Feb 21, 2025 | AWARD | 41,500 | — | — | Form 4 |
| Fahey Sandell Jacquelyn | Chief Legal Officer | Feb 21, 2025 | AWARD | 83,000 | $4.22 | $350.3K | Form 4 |
| Ferguson Toby | Chief Medical Officer | Feb 21, 2025 | AWARD | 63,000 | — | — | Form 4 |
| Ferguson Toby | Chief Medical Officer | Feb 21, 2025 | AWARD | 126,000 | $4.22 | $531.7K | Form 4 |
| Jorgensen Nathan D. | Chief Financial Officer | Feb 21, 2025 | AWARD | 51,500 | — | — | Form 4 |
| Jorgensen Nathan D. | Chief Financial Officer | Feb 21, 2025 | AWARD | 103,000 | $4.22 | $434.7K | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 11, 2025 | SELL | 5,413 | $4.45 | $24.1K | Form 4 |
| Swartz Robin | COO & CBO | Feb 11, 2025 | SELL | 6,950 | $4.45 | $30.9K | Form 4 |
| Sandrock Alfred | President & CEO | Feb 11, 2025 | SELL | 16,644 | $4.45 | $74.1K | Form 4 |
| Fahey Sandell Jacquelyn | Chief Legal Officer | Feb 11, 2025 | SELL | 4,358 | $4.45 | $19.4K | Form 4 |
| Swartz Robin | COO & CBO | Jan 14, 2025 | SELL | 3,087 | $5.09 | $15.7K | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Jan 14, 2025 | SELL | 1,191 | $5.13 | $6.1K | Form 4 |
| Swartz Robin | COO&CBO | Dec 23, 2024 | SELL | 6,500 | $5.65 | $36.7K | Form 4 |
| Fahey Sandell Jacquelyn | Chief Legal Officer | Oct 2, 2024 | SELL | 5,999 | $5.82 | $34.9K | Form 4 |
| Jorgensen Nathan D. | Chief Financial Officer | Oct 1, 2024 | AWARD | 80,000 | — | — | Form 4 |
| Jorgensen Nathan D. | Chief Financial Officer | Jul 8, 2024 | AWARD | 200,000 | $7.79 | $1.6M | Form 4 |
| Jorgensen Nathan D. | officer | Jul 8, 2024 | OTHER | 0 | — | — | Form 4 |
| Vitale Nancy | director | Jun 5, 2024 | AWARD | 24,000 | $8.70 | $208.8K | Form 4 |
| SCANGOS GEORGE A | director | Jun 5, 2024 | AWARD | 24,000 | $8.70 | $208.8K | Form 4 |
| PIERCE GLENN | director | Jun 5, 2024 | AWARD | 24,000 | $8.70 | $208.8K | Form 4 |
| Onyia Jude | director | Jun 5, 2024 | AWARD | 24,000 | $8.70 | $208.8K | Form 4 |
| MACKEY CATHERINE J | director | Jun 5, 2024 | AWARD | 24,000 | $8.70 | $208.8K | Form 4 |
| Hyman Steven | director | Jun 5, 2024 | AWARD | 24,000 | $8.70 | $208.8K | Form 4 |
| Higgins Michael J | director | Jun 5, 2024 | AWARD | 24,000 | $8.70 | $208.8K | Form 4 |
| GERAGHTY JAMES A | director | Jun 5, 2024 | AWARD | 24,000 | $8.70 | $208.8K | Form 4 |
| Colon Grace | director | Jun 5, 2024 | AWARD | 24,000 | $8.70 | $208.8K | Form 4 |
| Ferguson Toby | Chief Medical Officer | Apr 1, 2024 | AWARD | 105,000 | — | — | Form 4 |
| Swartz Robin | Chief Operating Officer | Apr 2, 2024 | SELL | 1,357 | $9.88 | $13.4K | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Apr 2, 2024 | SELL | 12,115 | $9.86 | $119.5K | Form 4 |
| Ferguson Toby | Chief Medical Officer | Mar 25, 2024 | AWARD | 210,000 | $9.26 | $1.9M | Form 4 |
| Ferguson Toby | officer | Mar 25, 2024 | OTHER | 0 | — | — | Form 4 |
| Swartz Robin | Chief Operating Officer | Feb 21, 2024 | SELL | 3,966 | $7.45 | $29.5K | Form 4 |
| Sandrock Alfred | director, officer: President and CEO | Feb 21, 2024 | SELL | 13,033 | $7.46 | $97.2K | Form 4 |
| PFREUNDSCHUH PETER P. | Chief Financial Officer | Feb 21, 2024 | SELL | 3,764 | $7.46 | $28.1K | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 20, 2024 | SELL | 602 | $7.68 | $4.6K | Form 4 |
| Carter Todd Alfred | Chief Scientific Officer | Feb 21, 2024 | SELL | 3,365 | $7.47 | $25.1K | Form 4 |
| Fahey Sandell Jacquelyn | Chief Legal Officer | Feb 9, 2024 | AWARD | 31,000 | — | — | Form 4 |
| Fahey Sandell Jacquelyn | Chief Legal Officer | Feb 9, 2024 | AWARD | 62,000 | $7.60 | $471.2K | Form 4 |